menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

AstraZeneca to buy cell therapy biotech for up to $1 billion

6 1
17.03.2025
AstraZeneca will pay $425 million upfront for EsoBiotec and may spend up to $575 million more in development and regulatory milestones, the companies said.

© Fortune